• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why NVIDIA Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket

    5/23/24 8:39:23 AM ET
    $AKTS
    $ASTI
    $BNED
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Semiconductors
    Technology
    Get the next $AKTS alert in real time by email

    Shares of NVIDIA Corporation (NASDAQ:NVDA) rose sharply in today's pre-market trading after the company reported better-than-expected financial results for its first quarter and issued strong guidance for the second quarter.

    The company announced a 10-for-1 stock split and raised its quarterly dividend by 150%.

    NVIDIA shares jumped 6.3% to $1,008.80 in the pre-market trading session.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Ascent Solar Technologies, Inc. (NASDAQ:ASTI) rose 178.8% to $0.3660 in today's pre-market trading after jumping 19% on Wednesday.
    • iSpecimen Inc. (NASDAQ:ISPC) shares gained 44% to $0.4610 in pre-market trading after jumping around 32% on Wednesday.
    • Netcapital Inc. (NASDAQ:NCPL) gained 42.6% to $0.2169 in pre-market trading.
    • Greenwave Technology Solutions, Inc. (NASDAQ:GWAV) gained 41.5% to $0.1115 in pre-market trading after jumping 34% on Wednesday.
    • Mustang Bio, Inc. (NASDAQ:MBIO) shares rose 18.8% to $0.2850 in pre-market trading after falling over 22% on Wednesday.
    • Sharps Technology, Inc. (NASDAQ:STSS) shares gained 14.8% to $0.2965 in pre-market trading.
    • LiveRamp Holdings, Inc. (NYSE:RAMP) shares climbed 14.4% to $37.00 in pre-market trading fter the company reported better-than-expected fourth-quarter financial results and issued first-quarter revenue guidance above estimates. Also, the company issued FY25 revenue guidance with its midpoint above estimates.
    • SU Group Holdings Limited (NASDAQ:SUGP) gained 12.5% to $2.96 in pre-market trading.
    • Zuora, Inc. (NYSE:ZUO) gained 10.5% to $10.89 in pre-market trading after the company reported better-than-expected first-quarter sales results and issued FY25 adjusted EPS guidance above estimates.

    Losers

    • MGO Global, Inc. (NASDAQ:MGOL) shares declined 36.7% to $0.7340 in pre-market trading after dipping over 7% on Wednesday.
    • Barnes & Noble Education, Inc. (NYSE:BNED) shares declined 32.7% to $0.7601 in pre-market trading after jumping 109% on Wednesday. Greenhaven last week said it continues to explore a possible transaction with the company.
    • Akoustis Technologies, Inc. (NASDAQ:AKTS) shares dipped 32.3% to $0.2134 in pre-market trading after jumping over 128% on Wednesday. Akoustis announced a $10 million registered direct offering priced at-the-market under Nasdaq rules.
    • DermTech, Inc. (NASDAQ:DMTK) shares fell 20.2% to $0.3350 in pre-market trading after jumping 18% on Wednesday.
    • Roadzen, Inc. (NASDAQ:RDZN) shares fell 19.1% to $3.18 in pre-market trading after jumping around 20% on Wednesday.
    • V.F. Corporation (NYSE:VFC) shares declined 15.2% to $10.46 in pre-market trading following worse-than-expected fourth-quarter financial results. VF Corporation named Paul Vogel as Chief Financial Officer.
    • Exela Technologies, Inc. (NASDAQ:XELA) shares fell 14.7% to $2.37 in pre-market trading. Exela Technologies recently posted a first-quarter loss of $4.27 per share.
    • Cytokinetics, Incorporated (NASDAQ:CYTK) shares fell 14.7% to $50.55 in pre-market trading. Cytokinetics priced its public offering of 9,803,922 common stock at $51 per share.
    • MultiMetaVerse Holdings Limited (NASDAQ:MMV) fell 13.6% to $0.8192 in pre-market trading.
    • Nxu, Inc. (NASDAQ:NXU) shares fell 13.6% to $0.50 in pre-market trading. Nxu shares jumped 29% on Wednesday after the company was issued a vehicle technology patent.

    Now Read This: Nvidia, BJ’s Wholesale Club And 3 Stocks To Watch Heading Into Thursday

    Get the next $AKTS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AKTS
    $ASTI
    $BNED
    $CYTK

    CompanyDatePrice TargetRatingAnalyst
    V.F. Corporation
    $VFC
    2/23/2026$18.00Neutral → Underweight
    Analyst
    Aktis Oncology Inc.
    $AKTS
    2/3/2026$30.00Overweight
    Analyst
    Aktis Oncology Inc.
    $AKTS
    2/3/2026$34.00Buy
    BofA Securities
    Aktis Oncology Inc.
    $AKTS
    2/3/2026$31.00Outperform
    Leerink Partners
    Aktis Oncology Inc.
    $AKTS
    2/3/2026Buy
    TD Cowen
    V.F. Corporation
    $VFC
    1/29/2026$16.00 → $20.00Market Perform
    Telsey Advisory Group
    Cytokinetics Incorporated
    $CYTK
    1/28/2026$87.00Overweight
    Barclays
    NVIDIA Corporation
    $NVDA
    1/15/2026$240.00Outperform
    RBC Capital Mkts
    More analyst ratings

    $AKTS
    $ASTI
    $BNED
    $CYTK
    SEC Filings

    View All

    SEC Form 10-K filed by NVIDIA Corporation

    10-K - NVIDIA CORP (0001045810) (Filer)

    2/25/26 4:42:19 PM ET
    $NVDA
    Semiconductors
    Technology

    NVIDIA Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - NVIDIA CORP (0001045810) (Filer)

    2/25/26 4:31:25 PM ET
    $NVDA
    Semiconductors
    Technology

    Amendment: SEC Form S-1/A filed by Netcapital Inc.

    S-1/A - Netcapital Inc. (0001414767) (Filer)

    2/24/26 4:40:35 PM ET
    $NCPL
    Finance: Consumer Services
    Finance

    $AKTS
    $ASTI
    $BNED
    $CYTK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CORRECTED VERSION: Ascent Solar Technologies' PV Blankets to Power NOVI AI Geo-Intelligence Spacecraft, N1-ATLAS, Scheduled for Launch This Spring

    THORNTON, Colo., Feb. 25, 2026 (GLOBE NEWSWIRE) --  Ascent Solar Technologies ("Ascent" or the "Company") (NASDAQ:ASTI), the leading U.S. innovator in the design and manufacturing of featherweight, flexible thin-film photovoltaic (PV) solutions, today announced that its previously delivered solar blankets have been successfully integrated into NOVI's N-1 ATLAS spacecraft, scheduled to fly on the upcoming SpaceX Falcon 9 Transporter-16 launch next month. NOVI's spring mission will demonstrate GENIE™ (Geospatial Ecosystem for Near Real-Time Information at the Edge), the company's flagship open-access, multi-sensor, edge-compute platform designed to provide low-cost, low-latency Earth observ

    2/25/26 4:39:35 PM ET
    $ASTI
    Semiconductors
    Technology

    NVIDIA Announces Financial Results for Fourth Quarter and Fiscal 2026

    Record quarterly revenue of $68.1 billion, up 20% from Q3 and up 73% from a year agoRecord quarterly Data Center revenue of $62.3 billion, up 22% from Q3 and up 75% from a year agoRecord full-year revenue of $215.9 billion, up 65% SANTA CLARA, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- NVIDIA (NASDAQ:NVDA) today reported record revenue for the fourth quarter ended January 25, 2026, of $68.1 billion, up 20% from the previous quarter and up 73% from a year ago. For fiscal 2026, revenue was $215.9 billion, up 65% from a year ago. For the quarter, GAAP and non-GAAP gross margins were 75.0% and 75.2%, respectively. For fiscal 2026, GAAP and non-GAAP gross margins were 71.1% and

    2/25/26 4:31:17 PM ET
    $NVDA
    Semiconductors
    Technology

    Sharps Technology and The Tie Announce Strategic Collaboration to Advance Institutional Participation in the Solana Ecosystem

    NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. ("STSS" or the "Company") (NASDAQ:STSS), a medical device company with a Solana digital asset treasury strategy, and The Tie, Inc. ("The Tie"), the leading provider of institutional-grade digital asset analytics, compliant communications, and infrastructure services, today announced a strategic collaboration to strengthen Solana's institutional infrastructure and expand institutional access to the ecosystem. Under the collaboration, STSS will delegate a portion of its SOL treasury holdings, currently more than 2 million SOL, to Stakin by The Tie, which operates non-custodial validator infrastructure across 40+ proof-o

    2/25/26 9:00:00 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    $AKTS
    $ASTI
    $BNED
    $CYTK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CHIEF REVENUE OFFICER Sharma Vihan covered exercise/tax liability with 5,230 shares, decreasing direct ownership by 4% to 123,915 units (SEC Form 4)

    4 - LiveRamp Holdings, Inc. (0000733269) (Issuer)

    2/23/26 4:48:59 PM ET
    $RAMP
    EDP Services
    Technology

    CHIEF PRODUCT OFFICER Karasick Matthew covered exercise/tax liability with 767 shares, decreasing direct ownership by 0.84% to 90,479 units (SEC Form 4)

    4 - LiveRamp Holdings, Inc. (0000733269) (Issuer)

    2/23/26 4:35:10 PM ET
    $RAMP
    EDP Services
    Technology

    CHIEF TECHNOLOGY OFFICER Hussain Mohsin covered exercise/tax liability with 2,235 shares, decreasing direct ownership by 4% to 58,379 units (SEC Form 4)

    4 - LiveRamp Holdings, Inc. (0000733269) (Issuer)

    2/23/26 4:32:24 PM ET
    $RAMP
    EDP Services
    Technology

    $AKTS
    $ASTI
    $BNED
    $CYTK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Foley Todd converted options into 4,002,533 shares and bought $4,191,660 worth of shares (232,870 units at $18.00) (SEC Form 4)

    4 - Aktis Oncology, Inc. (0002035832) (Issuer)

    1/14/26 6:20:21 PM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Mpm Bioventures 2018, L.P. converted options into 8,805,578 shares and bought $20,029,986 worth of shares (1,112,777 units at $18.00) (SEC Form 4)

    4 - Aktis Oncology, Inc. (0002035832) (Issuer)

    1/14/26 6:19:26 PM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Gadicke Ansbert converted options into 8,805,578 shares and bought $20,029,986 worth of shares (1,112,777 units at $18.00) (SEC Form 4)

    4 - Aktis Oncology, Inc. (0002035832) (Issuer)

    1/14/26 6:17:54 PM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKTS
    $ASTI
    $BNED
    $CYTK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    V.F. Corp downgraded by Analyst with a new price target

    Analyst downgraded V.F. Corp from Neutral to Underweight and set a new price target of $18.00

    2/23/26 8:34:02 AM ET
    $VFC
    Garments and Clothing
    Industrials

    Analyst initiated coverage on Aktis Oncology with a new price target

    Analyst initiated coverage of Aktis Oncology with a rating of Overweight and set a new price target of $30.00

    2/3/26 6:54:43 AM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    BofA Securities initiated coverage on Aktis Oncology with a new price target

    BofA Securities initiated coverage of Aktis Oncology with a rating of Buy and set a new price target of $34.00

    2/3/26 6:54:33 AM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKTS
    $ASTI
    $BNED
    $CYTK
    Leadership Updates

    Live Leadership Updates

    View All

    LiveRamp Appoints Commerce Media Pioneer Kristi Argyilan to Board of Directors

    LiveRamp (NYSE:RAMP), the leading data collaboration network, today announced that Kristi Argyilan has been appointed to the Company's Board of Directors. Argyilan currently serves as Global Head of Advertising at Uber, where she is leading the expansion of the company's mobility and delivery advertising business. Argyilan is widely recognized as the pioneer of retail media. Before joining Uber, she served as Senior Vice President of Retail Media at Albertsons Companies, where she led the growth of Albertsons Media Collective and championed the industry-wide move toward measurement standardization. Argyilan's appointment comes as LiveRamp accelerates its mission to scale the essential d

    2/17/26 8:30:00 AM ET
    $RAMP
    EDP Services
    Technology

    Greenwave Announces Appointment of Chelsea Pullano as Chief Financial Officer

    Chesapeake, VA, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Greenwave Technology Solutions, Inc. ("Greenwave" or the "Company") (NASDAQ:GWAV), an operator of metal recycling facilities in Virginia, North Carolina, and Ohio, today announced that the board of directors ("Board") of the Company appointed Chelsea Pullano as Chief Financial Officer of the Company, effective February 5, 2026. Ms. Pullano's appointment is in connection with the Company's entry into the scope of work agreement with MACK Financial Solutions, LLC ("MACK"), dated January 2, 2026, pursuant to which MACK agreed to provide professional services to the Company, including oversight of all bookkeeping, financial reporting and SEC r

    2/10/26 4:15:00 PM ET
    $GWAV
    Metal Fabrications
    Industrials

    Cytokinetics and Olympic Gold Medalist Sydney McLaughlin-Levrone Team Up to Raise Awareness of the Whole-Person Impact of Hypertrophic Cardiomyopathy (HCM)

    "On Track with HCM" Features Practical Insights for Managing Everyday Life with the Disease, Inspired by the Experience with HCM of McLaughlin-Levrone's Father, Willie McLaughlin SOUTH SAN FRANCISCO, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) today announced the launch of "On Track with HCM," demonstrating the company's long-standing commitment to the HCM community. The campaign features four-time Olympic gold medalist Sydney McLaughlin-Levrone, and her father, three-time all-American track star, Willie McLaughlin, who suffered from the non-obstructive form of hypertrophic cardiomyopathy (HCM) for more than two decades before receiving a heart trans

    1/27/26 8:00:00 AM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKTS
    $ASTI
    $BNED
    $CYTK
    Financials

    Live finance-specific insights

    View All

    NVIDIA Announces Financial Results for Fourth Quarter and Fiscal 2026

    Record quarterly revenue of $68.1 billion, up 20% from Q3 and up 73% from a year agoRecord quarterly Data Center revenue of $62.3 billion, up 22% from Q3 and up 75% from a year agoRecord full-year revenue of $215.9 billion, up 65% SANTA CLARA, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- NVIDIA (NASDAQ:NVDA) today reported record revenue for the fourth quarter ended January 25, 2026, of $68.1 billion, up 20% from the previous quarter and up 73% from a year ago. For fiscal 2026, revenue was $215.9 billion, up 65% from a year ago. For the quarter, GAAP and non-GAAP gross margins were 75.0% and 75.2%, respectively. For fiscal 2026, GAAP and non-GAAP gross margins were 71.1% and

    2/25/26 4:31:17 PM ET
    $NVDA
    Semiconductors
    Technology

    Cytokinetics Reports Fourth Quarter 2025 Financial Results and Provides Business Update

    MYQORZO® Approved for Adults with Symptomatic Obstructive HCM in U.S., China and Europe; U.S. Launch Underway with First Prescriptions Dispensed within Days of Drug Availability Supplemental NDA for MAPLE-HCM Submitted to FDA in Q1 2026 Expect to Share Topline Results from ACACIA-HCM in Q2 2026 Company Provides 2026 Financial Guidance;~$1.2 Billion in Cash, Cash Equivalents and Investments as of December 31, 2025 SOUTH SAN FRANCISCO, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) reported a management update and financial results for the fourth quarter and full year of 2025. The company also provided full year 2026 financial guidance. "The fourth qu

    2/24/26 4:00:00 PM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Roadzen Reports Strongest Quarter in Two Years with $14.4 Million Third Quarter Revenue and Sixth Consecutive Quarter of Adjusted EBITDA Improvement

    Roadzen delivers 18.8% revenue increase and reduces operating loss by 25.4% over prior-year quarter Strategic wins, new contracts and acquisitions, expand Roadzen's U.S. market presence and full-stack operating capabilities, reinforcing its position as a global AI leader at the intersection of insurance and mobility Year-over-year Sequential Revenue Growth; Record Nine-Month RevenueQ3 revenue increased 18.8% over the prior-year quarter and 4.9% from Q2 to $14.4 million; nine-month revenue rose 18.3% to $38.9 million, marking a record nine months and Roadzen's best quarter in the last two years.Operating Loss Continue to Materially Decline; Sixth Consecutive Quarter of Adjusted EBITDA1 impr

    2/12/26 4:05:00 PM ET
    $RDZN
    Specialty Insurers
    Finance

    $AKTS
    $ASTI
    $BNED
    $CYTK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Greenwave Technology Solutions Inc.

    SC 13G - Greenwave Technology Solutions, Inc. (0001589149) (Subject)

    12/5/24 10:00:25 AM ET
    $GWAV
    Metal Fabrications
    Industrials

    Amendment: SEC Form SC 13D/A filed by Exela Technologies Inc.

    SC 13D/A - Exela Technologies, Inc. (0001620179) (Subject)

    12/3/24 4:01:40 PM ET
    $XELA
    Business Services
    Consumer Discretionary

    SEC Form SC 13D filed by Exela Technologies Inc.

    SC 13D - Exela Technologies, Inc. (0001620179) (Subject)

    11/27/24 5:57:16 PM ET
    $XELA
    Business Services
    Consumer Discretionary